Merck Enlists Life Tech to Develop Companion Test for Cancer Drug, Other Pipeline Opportunities | GenomeWeb

Merck Serono has engaged Life Technologies to help it advance molecular diagnostics that can pick out best responders to its treatments.

The collaboration is initially centered on an unnamed oncology drug, according to the partners. However, the deal holds opportunities for Life Tech to help Merck advance multiple drugs in a variety of therapeutic areas with a personalized, biomarker-driven strategy.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.